Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Liabilities and Shareholders Equity (2019 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Liabilities and Shareholders Equity for 7 consecutive years, with $1.3 billion as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 27.26% to $1.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.6 billion through Dec 2025, up 27.82% year-over-year, with the annual reading at $1.3 billion for FY2025, 27.26% up from the prior year.
  • Liabilities and Shareholders Equity hit $1.3 billion in Q4 2025 for Harmony Biosciences Holdings, up from $1.2 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.3 billion in Q4 2025 to a low of $337.3 million in Q1 2021.
  • Historically, Liabilities and Shareholders Equity has averaged $757.4 million across 5 years, with a median of $769.0 million in 2023.
  • Biggest five-year swings in Liabilities and Shareholders Equity: grew 1.49% in 2021 and later skyrocketed 64.53% in 2022.
  • Year by year, Liabilities and Shareholders Equity stood at $433.4 million in 2021, then soared by 55.47% to $673.9 million in 2022, then grew by 20.42% to $811.4 million in 2023, then rose by 23.14% to $999.2 million in 2024, then grew by 27.26% to $1.3 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for HRMY at $1.3 billion in Q4 2025, $1.2 billion in Q3 2025, and $1.1 billion in Q2 2025.